Security key
36338D108
Galera Therapeutics, Inc. - Common stock, par value $0.001 per share (the "Common Stock") (GRTX)
CUSIP: 36338D108
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common stock, par value $0.001 per share (the "Common Stock")
- Total 13F shares
- 10,418,388
- Total 13F value
- $18,126,854
- Share change
- -128,522
- SEC-reported price per share
- $1.74
- Number of holders
- 29
- Value change
- -$188,443
- Number of buys
- 6
- Number of sells
- 15
- Shares outstanding
- 203,337,158
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
29
Top holders
10
GRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Galera Therapeutics, Inc. SEC filings
Galera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36338D108
Recent filing periods:
Ownership snapshot
Top reported holders of GRTX - Galera Therapeutics, Inc. - Common stock, par value $0.001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sofinnova Investments, Inc.
Disclosed value leader
Sofinnova Investments, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 1.5%
Showing 1-6 of 15 holder rows.
Quick read
Sofinnova Investments, Inc. leads the comparable SEC ownership view at 1.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sofinnova Investments, Inc.'s linked filing trail.
Comparable ownership
Top 5
Sofinnova Investments, Inc.
1.5%
Novo Holdings A/S
1.2%
Blackstone Inc.
0.83%
Tekla Capital Management LLC
0.44%
Nan Fung Group Holdings Ltd
0.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. |
13F
Company
|
1.5%
|
$4,009,000
3,083,712 shares
|
— | 30 Jun 2022 |
| Novo Holdings A/S |
13F
Company
|
1.2%
|
$3,197,000
2,459,021 shares
|
— | 30 Jun 2022 |
| Blackstone Inc. |
13F
Company
|
0.83%
|
$2,183,000
1,678,984 shares
|
— | 30 Jun 2022 |
| Tekla Capital Management LLC |
13F
Company
|
0.44%
|
$1,168,000
898,374 shares
|
— | 30 Jun 2022 |
| Nan Fung Group Holdings Ltd |
13F
Company
|
0.3%
|
$797,000
613,223 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
0.21%
|
$567,000
435,974 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
10,418,388
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
36
Q3 2022 holders
29
Holder diff
-7
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend